View More Recent Stories

Sep 18, 2024 07:24AM Zevra Therapeutics, Inc. (ZVRA) PT Lowered to $22 at Canaccord Genuity

Sep 6, 2024 10:14AM Roth/MKM Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)

Aug 13, 2024 05:02PM Zevra Therapeutics, Inc. (ZVRA) Misses Q2 EPS by 2c

Aug 9, 2024 06:20AM Zevra Therapeutics (ZVRA) Prices 9.23M Share Offering at $6.50/sh

Aug 8, 2024 04:01PM Zevra Therapeutics (ZVRA) Announces Proposed Share Offering

Jul 10, 2024 08:29AM H.C. Wainwright Reiterates Buy Rating on Zevra Therapeutics, Inc. (ZVRA)

Jul 9, 2024 02:17PM William Blair Reiterates Outperform Rating on Zevra Therapeutics, Inc. (ZVRA)

Jul 9, 2024 09:06AM Zevra (ZVRA) Announces FDA Advisory Committee Meeting to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C

Jun 10, 2024 12:24PM Cantor Fitzgerald Reiterates Overweight Rating on Zevra Therapeutics, Inc. (ZVRA)

View More Recent Stories